Leading Professional Society for Computational Biology and Bioinformatics
Connecting, Training, Empowering, Worldwide


CHI’s Structure-Based Drug Design
United States - MA - Boston

Hosted by:Cambridge Healthtech Institute
Venue:Seaport World Trade Center
Dates:May 21, 2014 through May 22, 2014

Experimental methods such as X-ray crystallography, NMR, and computational chemistry techniques have led to a better understanding and larger knowledge base of 3-dimensional structures and binding events, encouraging rapid development of structure-based drug design. Cambridge Healthtech Institute’s Fourteenth Annual Structure-Based Drug Design event will showcase informative, high-quality case studies, innovative techniques, and strategies to move from computation to experiment, and finally, to drug. Top scientists from pharma and biotech will address how they are hitting epigenetic targets, provide updates on the newest wave of GPCRs and other membrane proteins, and discuss the latest in fragment-based drug design. Attendees will return to their organizations with fresh perspectives and new ideas to maximize productivity and increase successes in drug discovery.

Keynote Speaker

Chas Bountra, Ph.D., Professor, Translational Medicine, Department of Clinical Medicine; Associate Head, Medical Sciences; Chief Scientist, Structural Genomics Consortium, University of Oxford

What’s New This Year:

* Coverage of novel targets and compounds including macrocycles, epigenetic targets, and BACE inhibitors

* Case studies and experimental follow-up - see how Constellation, Heptares, AstraZeneca, and others are leading the SBDD charge

* Expanded sessions on GPCR design and drug discovery

* Showcase of different approaches for working with the similar targets
Additional Information
Event URL:http://www.healthtech.com/structure-based-drug-design
ISCB Member Discount:10 percent
Contact Person:James Prudhomme ([javascript protected email address])

While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.